{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Experimental+2&page=46", "query": { "intervention": "Experimental 2", "page": 46 }, "page_size": 10 }, "pagination": { "page": 46, "page_size": 10, "total_count": 4117, "total_pages": 412, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Experimental+2&page=47&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Experimental+2&page=45&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-12T09:45:51.192Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07694739", "title": "E-cigarette Social Media Marketing and Its Perceptions by Youth", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Vaping" ], "interventions": [ { "name": "Exposure to Influencer Age and Context Variations in E-Cigarette Marketing", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Southern California", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "14 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "14 Years to 17 Years" }, "enrollment_count": 6000, "start_date": "2027-01-01", "completion_date": "2030-12-30", "has_results": false, "last_update_posted_date": "2026-07-20", "last_synced_at": "2026-11-12T09:45:51.192Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07694739" }, { "nct_id": "NCT01907100", "title": "Nintedanib (BIBF 1120) in Mesothelioma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Mesothelioma" ], "interventions": [ { "name": "Nintedanib", "type": "DRUG" }, { "name": "Pemetrexed", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 545, "start_date": "2013-09-19", "completion_date": "2018-08-31", "has_results": true, "last_update_posted_date": "2019-03-18", "last_synced_at": "2026-11-12T09:45:51.192Z", "location_count": 10, "location_summary": "Birmingham, Alabama • San Francisco, California • Littleton, Colorado + 7 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Francisco", "state": "California" }, { "city": "Littleton", "state": "Colorado" }, { "city": "Henderson", "state": "Nevada" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01907100" }, { "nct_id": "NCT07546500", "title": "A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ovarian Cancer" ], "interventions": [ { "name": "Investigator's choice of Chemotherapy", "type": "DRUG" }, { "name": "Azenosertib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 420, "start_date": "2026-04-17", "completion_date": "2030-04-30", "has_results": false, "last_update_posted_date": "2026-11-09", "last_synced_at": "2026-11-12T09:45:51.192Z", "location_count": 16, "location_summary": "Phoenix, Arizona • Antioch, California • Beverly Hills, California + 12 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Antioch", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07546500" }, { "nct_id": "NCT02595463", "title": "Intravenous Lidocaine for Post-Tonsillectomy Pain in Pediatric Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Pain" ], "interventions": [ { "name": "Lidocaine", "type": "DRUG" }, { "name": "Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ann & Robert H Lurie Children's Hospital of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "10 Years", "sex": "ALL", "summary": "4 Years to 10 Years" }, "enrollment_count": 89, "start_date": "2015-11", "completion_date": "2024-07-05", "has_results": false, "last_update_posted_date": "2024-11-12", "last_synced_at": "2026-11-12T09:45:51.192Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02595463" }, { "nct_id": "NCT00258557", "title": "TMC114-C211: Trial of an Investigational Protease Inhibitor TMC114 With Ritonavir (\"TMC114/r\") in HIV-1 Infected Patients Who Have Never Been Treated With Antiretroviral Medications.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "HIV" ], "interventions": [ { "name": "LPV/RTV", "type": "DRUG" }, { "name": "TMC-114/RTV", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tibotec Pharmaceuticals, Ireland", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 692, "start_date": "2005-09", "completion_date": "2012-05", "has_results": false, "last_update_posted_date": "2013-06-26", "last_synced_at": "2026-11-12T09:45:51.192Z", "location_count": 24, "location_summary": "Phoenix, Arizona • Beverly Hills, California • Long Beach, California + 21 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00258557" }, { "nct_id": "NCT04812028", "title": "Magnesium Sulfate for Analgesia in Pediatric Transplant", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Postoperative Pain" ], "interventions": [ { "name": "Magnesium sulfate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "3 Years to 18 Years" }, "enrollment_count": 66, "start_date": "2021-03-01", "completion_date": "2023-08-10", "has_results": true, "last_update_posted_date": "2024-10-28", "last_synced_at": "2026-11-12T09:45:51.192Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04812028" }, { "nct_id": "NCT06710392", "title": "Efficacy of Two Enzyme Cocktails in Healthy Adults", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Digestive", "Gastrointestinal Health" ], "interventions": [ { "name": "Enzyme Cocktail A", "type": "DIETARY_SUPPLEMENT" }, { "name": "Enzyme Cocktail B", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo A", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo B", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "The Archer-Daniels-Midland Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 18, "start_date": "2025-05-29", "completion_date": "2026-02-28", "has_results": false, "last_update_posted_date": "2026-05-12", "last_synced_at": "2026-11-12T09:45:51.192Z", "location_count": 1, "location_summary": "Denton, Texas", "locations": [ { "city": "Denton", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06710392" }, { "nct_id": "NCT07905131", "title": "A Study of Perioperative Navlimetostat Combined With Modified FOLFIRINOX in Patients With MTAP-Deleted Pancreatic Cancer", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Pancreatic Ductal Adenocarcinoma (PDAC)" ], "interventions": [ { "name": "Navlimetostat", "type": "DRUG" }, { "name": "mFOLFIRINOX Treatment Regimen", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daniel Nussbaum, M.D.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 18, "start_date": "2027-01-15", "completion_date": "2031-06-30", "has_results": false, "last_update_posted_date": "2026-11-02", "last_synced_at": "2026-11-12T09:45:51.192Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT07905131" }, { "nct_id": "NCT03616145", "title": "Effects of Osteopathic Manipulative Treatment (OMT) on Gait Biomechanics in Parkinson's Disease", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Parkinson Disease" ], "interventions": [ { "name": "Osteopathic Manipulative Treatment (OMT)", "type": "PROCEDURE" }, { "name": "Light Touch", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 94, "start_date": "2018-07-01", "completion_date": "2024-01-21", "has_results": false, "last_update_posted_date": "2023-11-13", "last_synced_at": "2026-11-12T09:45:51.192Z", "location_count": 1, "location_summary": "La Jolla, California", "locations": [ { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03616145" }, { "nct_id": "NCT06734039", "title": "Impact of Anatomy-Based Cochlear Implant Programming on Early Performance", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hearing Loss, Unilateral", "Cochlear Implants", "Hearing Loss, Sensorineural", "Single-Sided Deafness (SSD)", "Asymmetric Hearing Loss" ], "interventions": [ { "name": "Programming of cochlear implant audio processor frequency settings", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Med-El Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2025-11-10", "completion_date": "2028-10", "has_results": false, "last_update_posted_date": "2026-03-27", "last_synced_at": "2026-11-12T09:45:51.192Z", "location_count": 6, "location_summary": "Iowa City, Iowa • Kansas City, Kansas • Chapel Hill, North Carolina + 3 more", "locations": [ { "city": "Iowa City", "state": "Iowa" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT06734039" } ] }